[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Renergen Ltd (RLT.AX)

Renergen Ltd (RLT.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Renergen Ltd 25 Minerva Avenue Sandton Gate, Glenadrienne Sandton 2196 ZAF

https://www.renergen.co.za P: +27 100456000 F: +27 100456001

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Renergen Ltd is an investment holding company focused on the alternative and renewable energy sectors in South Africa and sub-Saharan Africa. Its reportable segments are the Corporate Head office where all investment decisions are made; Tetra4 which explores, produces, and sells LNG in South Africa; Cryovation which has developed Cryo-VaccTM technology, and enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power; and the Renergen U.S segment which assists with various fundraising and business development activities of the Group in the U.S market. The majority of the company's revenue is generated from the Tetra4 segment.

Key Statistics

Overview:

Market Capitalization, $K 129,091
Shares Outstanding, K 155,171
% of Institutional Shareholders 0.40%

Financials:

Annual Sales, $ 52,113 K
Annual Net Income, $ -236,120 K

Growth:

1-Year Return 27.12%
3-Year Return -63.77%
5-Year Return -33.92%
5-Year Revenue Growth 81.65%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -2.05
Dividend Payout Ratio 0.00%

RLT.AX Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -29.52%
Return-on-Assets % -11.81%
Profit Margin % -453.09%
Debt/Equity 0.06
Price/Sales 22.14
Price/Book 1.47
Book Value/Share 0.51
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.